DrugPatentWatch Database Preview
SULAR Drug Profile
» See Plans and Pricing
When do Sular patents expire, and what generic alternatives are available?
Sular is a drug marketed by Covis and is included in one NDA.
The generic ingredient in SULAR is nisoldipine. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the nisoldipine profile page.
US ANDA Litigation and Generic Entry Outlook for Sular
A generic version of SULAR was approved as nisoldipine by MYLAN on July 25th, 2008.
Summary for SULAR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Suppliers / Packagers: | 2 |
Bulk Api Vendors: | 90 |
Patent Applications: | 3,877 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for SULAR |
What excipients (inactive ingredients) are in SULAR? | SULAR excipients list |
DailyMed Link: | SULAR at DailyMed |


Pharmacology for SULAR
Drug Class | Dihydropyridine Calcium Channel Blocker |
Mechanism of Action | Calcium Channel Antagonists |
Physiological Effect | Decreased Blood Pressure |
Paragraph IV (Patent) Challenges for SULAR
Tradename | Dosage | Ingredient | NDA | Submissiondate |
---|---|---|---|---|
SULAR | TABLET, EXTENDED RELEASE;ORAL | nisoldipine | 020356 | 2009-03-02 |
SULAR | TABLET, EXTENDED RELEASE;ORAL | nisoldipine | 020356 | 2008-11-28 |
SULAR | TABLET, EXTENDED RELEASE;ORAL | nisoldipine | 020356 | 2007-11-07 |
SULAR | TABLET, EXTENDED RELEASE;ORAL | nisoldipine | 020356 | 2007-06-11 |
US Patents and Regulatory Information for SULAR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Covis | SULAR | nisoldipine | TABLET, EXTENDED RELEASE;ORAL | 020356-008 | Jan 2, 2008 | AB | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
Covis | SULAR | nisoldipine | TABLET, EXTENDED RELEASE;ORAL | 020356-005 | Jan 2, 2008 | AB | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
Covis | SULAR | nisoldipine | TABLET, EXTENDED RELEASE;ORAL | 020356-002 | Feb 2, 1995 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
Covis | SULAR | nisoldipine | TABLET, EXTENDED RELEASE;ORAL | 020356-004 | Feb 2, 1995 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
Covis | SULAR | nisoldipine | TABLET, EXTENDED RELEASE;ORAL | 020356-001 | Feb 2, 1995 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
Covis | SULAR | nisoldipine | TABLET, EXTENDED RELEASE;ORAL | 020356-007 | Jan 2, 2008 | AB | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SULAR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Covis | SULAR | nisoldipine | TABLET, EXTENDED RELEASE;ORAL | 020356-004 | Feb 2, 1995 | Start Trial | Start Trial |
Covis | SULAR | nisoldipine | TABLET, EXTENDED RELEASE;ORAL | 020356-002 | Feb 2, 1995 | Start Trial | Start Trial |
Covis | SULAR | nisoldipine | TABLET, EXTENDED RELEASE;ORAL | 020356-008 | Jan 2, 2008 | Start Trial | Start Trial |
Covis | SULAR | nisoldipine | TABLET, EXTENDED RELEASE;ORAL | 020356-001 | Feb 2, 1995 | Start Trial | Start Trial |
Covis | SULAR | nisoldipine | TABLET, EXTENDED RELEASE;ORAL | 020356-005 | Jan 2, 2008 | Start Trial | Start Trial |
Covis | SULAR | nisoldipine | TABLET, EXTENDED RELEASE;ORAL | 020356-004 | Feb 2, 1995 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SULAR
Country | Patent Number | Estimated Expiration |
---|---|---|
Germany | 69428862 | Start Trial |
Germany | 3870338 | Start Trial |
Denmark | 0656204 | Start Trial |
Germany | 3720757 | Start Trial |
Italy | 1237904 | Start Trial |
Spain | 2051800 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |